Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers

Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma

(2015) I. Janssen et al.   CLINICAL CANCER RESEARCH

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5

(2015) Diana E Benn et al.   ENDOCRINE-RELATED CANCER

15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma

(2015) Frédéric Castinetti et al.   ENDOCRINE-RELATED CANCER

15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma–paraganglioma syndromes characterized by germlineSDHBandSDHDmutations

(2015) Bora E Baysal et al.   ENDOCRINE-RELATED CANCER

Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort

(2015) Judit Dénes et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

(2014) Judith Favier et al.   Nature Reviews Endocrinology

Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families

(2013) Kory W. Jasperson et al.   Familial Cancer

High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations

(2012) Berdine L Heesterman et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma

(2012) David Taïeb et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma inSDHxMutation Carriers: A Multicenter Prospective Study from the PGL.EVA Investigators

(2012) Anne-Paule Gimenez-Roqueplo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pheochromocytoma – update on disease management

(2012) Roland Därr et al.   Therapeutic Advances in Endocrinology and Metabolism

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

(2011) Graeme Eisenhofer et al.   EUROPEAN JOURNAL OF CANCER

Are we overestimating the penetrance of mutations in SDHB?

(2010) Francesca Schiavi et al.   HUMAN MUTATION

Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours

(2009) Umasuthan Srirangalingam et al.   ENDOCRINE-RELATED CANCER

Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations inSDHBandSDHD

(2009) Christopher J. Ricketts et al.   HUMAN MUTATION

Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional Paragangliomas

(2009) Massimo Mannelli et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas

(2009) Nelly Burnichon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Whole-Body PET/CT Scanning: Estimation of Radiation Dose and Cancer Risk

(2009) Bingsheng Huang et al.   RADIOLOGY

Clinical manifestations of familial paraganglioma and phaeochromocytomas insuccinate dehydrogenase B(SDH-B) gene mutation carriers

(2008) Umasuthan Srirangalingam et al.   CLINICAL ENDOCRINOLOGY

Screening for familial paragangliomas

(2007) David Myssiorek et al.   ORAL ONCOLOGY